Lynn Jongen

430 total citations
13 papers, 237 citations indexed

About

Lynn Jongen is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Lynn Jongen has authored 13 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Lynn Jongen's work include Estrogen and related hormone effects (5 papers), Breast Cancer Treatment Studies (5 papers) and Advanced Breast Cancer Therapies (3 papers). Lynn Jongen is often cited by papers focused on Estrogen and related hormone effects (5 papers), Breast Cancer Treatment Studies (5 papers) and Advanced Breast Cancer Therapies (3 papers). Lynn Jongen collaborates with scholars based in Belgium, Netherlands and Italy. Lynn Jongen's co-authors include Patrick Neven, Giuseppe Floris, Hans Wildiers, Annouschka Laenen, Maartje Los, Vincent O. Dezentjé, Jesse J. Swen, Henk‐Jan Guchelaar, Ignace Vergote and Carolien H. Smorenburg and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

Lynn Jongen

13 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynn Jongen Belgium	7	132	105	99	51	47	13	237
Bryony Eccles United Kingdom	8	236 1.8×	115 1.1×	174 1.8×	44 0.9×	68 1.4×	11	363
Judy-Anne W. Chapman Canada	8	185 1.4×	138 1.3×	124 1.3×	41 0.8×	38 0.8×	9	358
Jacklyn N. Thibert United States	7	137 1.0×	161 1.5×	71 0.7×	148 2.9×	41 0.9×	9	336
Erdogan Batman Netherlands	6	86 0.7×	88 0.8×	37 0.4×	60 1.2×	29 0.6×	8	201
Erika Bågeman Sweden	8	129 1.0×	66 0.6×	47 0.5×	40 0.8×	11 0.2×	14	286
Amy Sion United States	5	115 0.9×	38 0.4×	41 0.4×	44 0.9×	98 2.1×	8	238
Radka Platte United Kingdom	4	59 0.4×	73 0.7×	53 0.5×	63 1.2×	84 1.8×	4	242
Pamela Provan Australia	10	109 0.8×	82 0.8×	120 1.2×	36 0.7×	28 0.6×	18	261
M. Navarro Spain	8	190 1.4×	61 0.6×	48 0.5×	20 0.4×	50 1.1×	16	327
Heather L. Blackburn United States	9	119 0.9×	58 0.6×	142 1.4×	17 0.3×	47 1.0×	12	349

Countries citing papers authored by Lynn Jongen

Since Specialization

Citations

This map shows the geographic impact of Lynn Jongen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Jongen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Jongen more than expected).

Fields of papers citing papers by Lynn Jongen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Jongen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Jongen. The network helps show where Lynn Jongen may publish in the future.

Co-authorship network of co-authors of Lynn Jongen

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Jongen. A scholar is included among the top collaborators of Lynn Jongen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Jongen. Lynn Jongen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Bempt, Isabelle Vanden, Hans Wildiers, Ann Smeets, et al.. (2021). Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2− early breast cancer. Modern Pathology. 34(7). 1297–1309. 7 indexed citations

Floris, Giuseppe, François Richard, Anne‐Sophie Hamy, et al.. (2020). Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 113(2). 146–153. 33 indexed citations

Dezentjé, Vincent O., Jesse J. Swen, Dirk Jan A. R. Moes, et al.. (2019). Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study. Journal of Clinical Oncology. 37(8). 636–646. 64 indexed citations

Jongen, Lynn, Giuseppe Floris, Hans Wildiers, et al.. (2019). Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy. Breast Cancer Research and Treatment. 176(3). 699–708. 19 indexed citations

Jongen, Lynn, Giuseppe Floris, Hans Wildiers, et al.. (2019). The prognostic role of the androgen receptor in patients with triple-negative early breast cancers and primary surgery.. Journal of Clinical Oncology. 37(15_suppl). e12042–e12042. 1 indexed citations

Jongen, Lynn, Kevin Punie, Sara Vander Borght, et al.. (2018). Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer. Clinical Drug Investigation. 38(11). 1071–1075. 3 indexed citations

Jongen, Lynn, Giuseppe Floris, Bram Boeckx, et al.. (2018). Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations. Breast Cancer Research and Treatment. 174(1). 55–63. 2 indexed citations

Olbrecht, Siel, Lynn Jongen, Olivier Brouckaert, et al.. (2018). Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer. The Oncologist. 24(2). 165–171. 28 indexed citations

Dezentjé, Vincent O., Jesse J. Swen, Dirk Jan A. R. Moes, et al.. (2018). A prospective study on the effect of endoxifen concentration and CYP2D6 phenotypes on clinical outcome in early stage breast cancer patients receiving adjuvant tamoxifen.. Journal of Clinical Oncology. 36(15_suppl). 523–523. 3 indexed citations

10.

Jongen, Lynn, Robert Paridaens, Giuseppe Floris, Hans Wildiers, & Patrick Neven. (2016). Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm. Breast Cancer Research and Treatment. 155(3). 603–607. 5 indexed citations

11.

Lintermans, Anneleen, Lynn Jongen, Thomas Van Brussel, et al.. (2016). Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients. European Journal of Cancer. 56. 31–36. 29 indexed citations

12.

Lambertini, Matteo, Ana Catarina Pinto, Lieveke Ameye, et al.. (2016). The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients. British Journal of Cancer. 115(12). 1471–1478. 40 indexed citations

13.

Lintermans, Anneleen, Lynn Jongen, Diether Lambrechts, et al.. (2016). Prospective study evaluating the effect of impaired tamoxifen metabolisation on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting.. Journal of Clinical Oncology. 34(15_suppl). 523–523. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact